Entera Bio announced that new comparative pharmacological data for its investigational agent EB613 vs. Forteo(R) was selected for presentation at the American Society for Bone and Mineral Research, ASBMR, 2024 Annual Meeting which will be held on September 27-30, 2024 in Toronto, ON, Canada.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue